{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:09:15Z","timestamp":1791043755240,"version":"4.1.0"},"reference-count":22,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1590\/s1677-55382010000600003","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T23:45:59Z","timestamp":1298591159000},"page":"665-669","source":"Crossref","is-referenced-by-count":41,"title":["The novel prostate cancer antigen 3 (PCA3) biomarker"],"prefix":"10.1590","volume":"36","author":[{"given":"Andreas","family":"Bourdoumis","sequence":"first","affiliation":[{"name":"Sismanoglio Hospital,  Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Papatsoris","sequence":"additional","affiliation":[{"name":"Sismanoglio Hospital,  Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chrisofos","sequence":"additional","affiliation":[{"name":"Sismanoglio Hospital,  Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Efstathiou","sequence":"additional","affiliation":[{"name":"Alexandra Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Skolarikos","sequence":"additional","affiliation":[{"name":"Sismanoglio Hospital,  Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Deliveliotis","sequence":"additional","affiliation":[{"name":"Sismanoglio Hospital,  Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/era.09.168","article-title":"Biomarkers for prostate cancer detection","volume":"10","author":"Reed AB","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.21032","article-title":"Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer","volume":"70","author":"Hessels D","year":"2010","journal-title":"Prostate","ISSN":"https:\/\/id.crossref.org\/issn\/0270-4137","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.puhe.2008.06.011","article-title":"Prostate cancer screening behaviour","volume":"123","author":"Papatsoris A","year":"2009","journal-title":"Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3492","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eururo.2006.04.021","article-title":"Interview with Jack Schalken: PCA3 and its use as a diagnostic test in prostate cancer. Interview by Christine McKillop","volume":"50","author":"Schalken J","year":"2006","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"issue":"6","key":"ref5","first-page":"255","article-title":"The use of PCA3 in the diagnosis of prostate cancer","volume":"2009","author":"Hessels D","journal-title":"Nat Rev Urol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pros.21040","article-title":"Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer","volume":"70","author":"Salagierski M","year":"2010","journal-title":"Prostate","ISSN":"https:\/\/id.crossref.org\/issn\/0270-4137","issn-type":"print"},{"key":"ref7","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers MJ","year":"1999","journal-title":"Cancer Res","ISSN":"https:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"ref8","first-page":"175","article-title":"Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice","volume":"10","author":"Marks LS","year":"2008","journal-title":"Rev Urol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2007.11.003","article-title":"A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy","volume":"389","author":"Sokoll LJ","year":"2008","journal-title":"Clin Chim Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.juro.2009.10.003","article-title":"Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program","volume":"183","author":"Tosoian JJ","year":"2010","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.urology.2009.03.046","article-title":"Urinary prostate cancer 3 test: toward the age of reason?","volume":"75","author":"Vlaeminck-Guillem V","year":"2010","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1464-410X.2008.08280.x","article-title":"Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)","volume":"103","author":"Kirby RS","year":"2009","journal-title":"BJU Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.juro.2007.11.038","article-title":"PCA3: a molecular urine assay for predicting prostate biopsy outcome","volume":"179","author":"Deras IL","year":"2008","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10408360601177236","article-title":"Precursor lesions of prostate cancer","volume":"44","author":"Chrisofos M","year":"2007","journal-title":"Crit Rev Clin Lab Sci","ISSN":"https:\/\/id.crossref.org\/issn\/1040-8363","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1464-410X.2009.09085.x","article-title":"The Prostate Cancer gene 3 assay: indications for use in clinical practice","volume":"105","author":"Schilling D","year":"2010","journal-title":"BJU Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2009.03.029","article-title":"Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram","volume":"56","author":"Chun FK","year":"2009","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2008.07.060","article-title":"PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume","volume":"180","author":"Whitman EJ","year":"2008","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2008.06.038","article-title":"Predicting prostate cancer risk through incorporation of prostate cancer gene 3","volume":"180","author":"Ankerst DP","year":"2008","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","article-title":"Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy","volume":"54","author":"Haese A","year":"2008","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.urology.2008.08.459","article-title":"PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting","volume":"73","author":"Shappell SB","year":"2009","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole GL","year":"2009","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.juro.2009.02.135","article-title":"Personalized prediction of tumor response and cancer progression on prostate needle biopsy","volume":"182","author":"Donovan MJ","year":"2009","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v36n6\/v36n6a03.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T20:41:23Z","timestamp":1495831283000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382010000600003&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1677-55382010000600003"],"URL":"https:\/\/doi.org\/10.1590\/s1677-55382010000600003","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}